Form 4: Director Susan T. Weaver Receives Addus HomeCare Equity

Director Susan T. Weaver was granted 1,449 restricted shares of Addus HomeCare Corp common stock.

Summary

• Director Susan T. Weaver acquired 1,449 shares of Addus HomeCare Corp (ADUS) common stock.
• The transaction occurred on June 10, 2026.
• The shares were granted as restricted stock units with a price of $0.
• Following this transaction, the director's total beneficial ownership is 13,744 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity compensation.

Negatives

• None identified.

Risks

• Vesting conditions apply to the granted shares, which will not fully vest until June 10, 2027.

Future Outlook

The restricted shares are scheduled to vest in full on June 10, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the healthcare services sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of restricted stock to directors is consistent with standard compensation practices for mid-cap healthcare companies.
• The one-year cliff vesting period is a common retention and alignment mechanism used by peers in the home health industry.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity-based compensation grant.

Next Steps

• Vesting of the 1,449 shares on June 10, 2027.

Key Dates

Keywords

Addus HomeCare, ADUS, Form 4, Insider Transaction, Director Compensation, Equity Grant